title: [Summary of the GEIPC-SEIMC and GTEI-SEMICYUC recommendations for the treatment of infections caused by gram positive cocci in critical patients].
abstract: OBJECTIVE
  In recent years there has been an increase in infections caused by gram-positive cocci in critical patients, together with a rapid development of resistance to the antibiotics which are normally used to treat them. The objective is to prepare an antibiotic treatment guide for the most common infections caused by gram positive cocci in critical patients. This guide will help in the decision-making process regarding the care of such patients.
  
  
  METHODS
  Experts from two scientific societies worked together to prepare a consensus document. They were members of the Study Group on Infections in Critical Patients (GEIPC), which is part of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), and the Infectious Diseases Working Group (GTEI), belonging to the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC). There was a systematic review of the literature published up to September 2006 regarding this type of infections and the antibiotic treatments marketed to that date. An evidence grading system was applied according to the strength of the recommendation (categories A, B or C) and the level of evidence (categories I, II or III). Recommendations were given if there was consensus among the experts from both societies.
  
  
  RESULTS
  The antibiotic regimens recommended for treating infections caused by gram-positive cocci were presented in the form of tables, showing the recommendation grade. Alternatives were given for allergic patients. The scientific basis supporting the aforementioned recommendations is explained within the text and the references upon which they are based are cited.
  
  
  CONCLUSIONS
  A summary of an evidence-based practical guide for the treatment of infections caused by gram-positive cocci in critical patients is presented.
authors.affiliation: Servicio de Medicina Intensiva, Hospital de Galdakao, Vizcaya, GEIPC, Spain. pedromaria.olaecheaastigarraga@osakidetza.net
authors.forename: P M
authors.initials: PM
authors.lastname: Olaechea Astigarraga
authors.forename: J
authors.initials: J
authors.lastname: Garnacho Montero
authors.forename: S
authors.initials: S
authors.lastname: Grau Cerrato
authors.forename: O
authors.initials: O
authors.lastname: Rodríguez Colomo
authors.forename: M
authors.initials: M
authors.lastname: Palomar Martínez
authors.forename: R
authors.initials: R
authors.lastname: Zaragoza Crespo
authors.forename: P
authors.initials: P
authors.lastname: Muñoz García-Paredes
authors.forename: E
authors.initials: E
authors.lastname: Cerdá Cerdá
authors.forename: F
authors.initials: F
authors.lastname: Alvarez Lerma
mesh_terms: D016638:Critical Illness; D003428:Cross Infection / Q000517:prevention & control; D016908:Gram-Positive Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy / Q000382:microbiology; D013211:Staphylococcus aureus / Q000302:isolation & purification; D013290:Streptococcal Infections / Q000150:complications / Q000188:drug therapy*; D013296:Streptococcus pneumoniae / Q000302:isolation & purification